Please join us for our Pear Bioreactor: Bench to Business speakers series with Kristen Fortney, CEO / co-founder of BioAge Labs. In our Bench to Business speaker series we feature top leaders across the Life Sciences and BioTech industry.
In this fireside chat, we'll learn more about Kristen's journey from a PhD student at University of Toronto, to a postdoc at Stanford, and then the founder and CEO at BioAge Labs, now a Series C-stage company developing treatments that target the molecular causes of human aging. We'll also her about the latest progress at BioAge Labs and where she thinks the aging field is headed.
We’ll be at Pear HQ in Menlo Park and will provide food and drinks. See you there!
— More about the speaker --
Kristen leads BioAge Labs in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BioAge's data-driven approach to identify and target the molecular pathways that drive aging.
Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.